BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma.

Li, Yibing; Huo, Jianing; He, Junjian; Zhang, Yunzheng; Ma, Xiaoxin

Li, Yibing; Huo, Jianing; He, Junjian; Zhang, Yunzheng; Ma, Xiaoxin.

Afiliação

Li Y; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Tiexi District, Shenyang, 110000 Liaoning People's Republic of China.
Huo J; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Tiexi District, Shenyang, 110000 Liaoning People's Republic of China.
He J; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Tiexi District, Shenyang, 110000 Liaoning People's Republic of China.
Zhang Y; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Tiexi District, Shenyang, 110000 Liaoning People's Republic of China.
Ma X; Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, 39 Huaxiang Road, Tiexi District, Shenyang, 110000 Liaoning People's Republic of China.

Cancer Cell Int ; 20: 490, 2020.

Article em En | MEDLINE | ID: mdl-33041670

Palavras-chave

Apoptosis; BTG1; Bioinformatics; EMT; Endometrial carcinoma; Invasion; Migration; Prognosis; Proliferation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google